NCT02441829View on ClinicalTrials.gov

Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Renal Function

PHASE1CompletedINTERVENTIONAL

Enrollment

55

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions

Long QT Syndrome

Interventions

DRUG

Eleclazine

Eleclazine tablets administered orally in morning with food

Trial Locations (7)

Unknown

DeLand

Miami

Orlando

Saint Paul

Kansas City

Chisinau

Bucharest

Sponsors

Lead Sponsor

Gilead Sciences

All Listed Sponsors

lead

Gilead Sciences

INDUSTRY